IMMUTOL
The paper recently published in the British Journal of Clinical Pharmacology is entitled: Early-stage health technology assessment of a curative gene therapy for multiple sclerosis. Link to the article: http://doi.org/10.1002/bcp.70204 As indicated in the paper…
read more
EMSP is the umbrella organization for national Multiple Sclerosis (MS) organizations in Europe and has been the leading voice for people with MS for over 30 years. EMSP works with members, partners, and…
read more
15th Società Italiana di Immunologia, Immunologia Clinica e Allergologia (SIICA 2025) in Perugia, Italy, 17-18 June 2025 Silvia Gregori (FTELE/OSR), presented her work on latest advances in the development of engineered…
read more
The 2nd Annual Meeting of IMMUTOL consortium took place in Budapest between the 27th and 28th of May, 2025 hosted by SRI and organised by INN-Acta. The first day of the event was…
read more
Alex Agundez-Moreno (IGTP) participated in the 45th National Congress of the Spanish Society of Immunology (Sociedad Española de Inmunología (SEI)), which took place in Santander, Spain, from May 22 to…
read more
SAVE THE DATE! IMMUTOL’s 2nd Annual Meeting will take place on May 27-28, 2025, at the Lion’s Garden Hotel in Budapest, Hungary.
read more
Luis Soria Jiménez, postdoctoral researcher and Ana María Barriocanal, MD, PhD joined the IMMUTOL projects from Institute de Investigacion en Ciencias de la Salut Germans Trias I Pujol. Welcome!
read more
Cristina Rosell, PhD recently joined the Immutol team from ASPHALION! Welcome!
read more
Daniëlle ter Braake (SQ) presented a poster, focused on preliminary results in setting up SQs B cell assays and shared her future plans at the NVVI conference in 2024 at…
read more